Alto Neuroscience Inc (ANRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 9,125 | 7,201 | 0 | 0 |
| Operating Income | -9,125 | -7,201 | N/A | N/A |
| Interest Expense | 327 | 324 | 0 | 0 |
| Other Income | 789 | 241 | 0 | 0 |
| Pre-tax Income | -8,663 | -7,284 | 0 | 0 |
| Net Income Continuous | -8,663 | -7,284 | N/A | N/A |
| Net Income | $-8,663 | $-7,284 | $N/A | $N/A |
| EPS Basic Total Ops | -2.33 | -1.97 | N/A | N/A |
| EPS Basic Continuous Ops | -2.33 | -1.97 | N/A | N/A |
| EPS Diluted Total Ops | -2.33 | -1.97 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.33 | -1.97 | N/A | N/A |
| EBITDA(a) | $-9,013 | $-7,115 | $N/A | $N/A |